- Home
- ATCH vs AEON Comparison
ATCH vs AEON Comparison
Compare ATCH & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATCH
- AEON
- Stock Information
- Founded
- ATCH 2022
- AEON N/A
- Country
- ATCH United States
- AEON United States
- Employees
- ATCH N/A
- AEON N/A
- Industry
- ATCH
- AEON Biotechnology: Pharmaceutical Preparations
- Sector
- ATCH
- AEON Health Care
- Exchange
- ATCH Nasdaq
- AEON Nasdaq
- Market Cap
- ATCH 9.0M
- AEON 8.0M
- IPO Year
- ATCH N/A
- AEON N/A
- Fundamental
- Price
- ATCH $0.36
- AEON $0.92
- Analyst Decision
- ATCH
- AEON Strong Buy
- Analyst Count
- ATCH 0
- AEON 1
- Target Price
- ATCH N/A
- AEON $7.20
- AVG Volume (30 Days)
- ATCH 121.5M
- AEON 139.8K
- Earning Date
- ATCH 11-14-2025
- AEON 11-12-2025
- Dividend Yield
- ATCH N/A
- AEON N/A
- EPS Growth
- ATCH N/A
- AEON N/A
- EPS
- ATCH 0.14
- AEON N/A
- Revenue
- ATCH $10,856,612.00
- AEON N/A
- Revenue This Year
- ATCH N/A
- AEON N/A
- Revenue Next Year
- ATCH N/A
- AEON N/A
- P/E Ratio
- ATCH $2.76
- AEON N/A
- Revenue Growth
- ATCH 171.31
- AEON N/A
- 52 Week Low
- ATCH $0.14
- AEON $0.38
- 52 Week High
- ATCH $26.94
- AEON $115.57
- Technical
- Relative Strength Index (RSI)
- ATCH 45.73
- AEON 73.70
- Support Level
- ATCH $0.45
- AEON $0.78
- Resistance Level
- ATCH $0.53
- AEON $0.85
- Average True Range (ATR)
- ATCH 0.13
- AEON 0.04
- MACD
- ATCH -0.06
- AEON 0.02
- Stochastic Oscillator
- ATCH 0.38
- AEON 100.00
About ATCH AtlasClear Holdings Inc. Common Stock
AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and innovative financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.